Falcon Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Liquidation

  • Investors
  • 1

Falcon Therapeutics General Information

Description

Developer of a personalized gene-modified cell therapy designed to kill cancer cells and minimize the potential of off-target toxicity. The company's therapy holds the potential to kill multiple cancer types including solid tumor cancers which cannot be effectively treated by currently approved immune-oncology therapies, enabling medical practitioners to treat cancer patients with efficacy.

Contact Information

Website
www.falcontherapeutics.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 701 West Main Street
  • Suite 200
  • Durham, NC 27701
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 701 West Main Street
  • Suite 200
  • Durham, NC 27701
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Falcon Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Bankruptcy: Liquidation 15-Sep-2021 Completed Bankruptcy: Liquidation
8. Grant 10-Mar-2019 Completed Pre-Clinical Trials
7. Early Stage VC 01-Jan-2019 Completed Generating Revenue
6. Debt - General 26-Feb-2018 Completed Generating Revenue
5. Debt - General 26-Sep-2017 Completed Generating Revenue
4. Seed Round 19-Jun-2017 Completed Generating Revenue
3. Grant 01-Jan-2017 Completed Generating Revenue
2. Grant $59K Completed Generating Revenue
1. University Spin-Out 01-Jan-2015 Completed Startup
To view Falcon Therapeutics’s complete valuation and funding history, request access »

Falcon Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
To view Falcon Therapeutics’s complete cap table history, request access »

Falcon Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a personalized gene-modified cell therapy designed to kill cancer cells and minimize the potential of off-t
Drug Discovery
Durham, NC
5 As of 2019

Abingdon, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Falcon Therapeutics Competitors (1)

One of Falcon Therapeutics’s competitors is Adaptimmune Therapeutics, a Formerly VC-backed company based in Abingdon, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
You’re viewing 1 of 1 competitors. Get the full list »

Falcon Therapeutics Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Falcon Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2020150391-A1 Engineered stem cell constructs and uses thereof Inactive 15-Jan-2019
US-20200222555-A1 Itdc compositions and methods for use in therapeutic methods Inactive 15-Jan-2019
WO-2020093003-A1 Tumor homing cell compositions for use in therapeutic methods Inactive 01-Nov-2018 A61K35/28

Falcon Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Falcon Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Center For Advancing Translational Sciences Government
To view Falcon Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Falcon Therapeutics FAQs

  • When was Falcon Therapeutics founded?

    Falcon Therapeutics was founded in 2015.

  • Where is Falcon Therapeutics headquartered?

    Falcon Therapeutics is headquartered in Durham, NC.

  • What is the size of Falcon Therapeutics?

    Falcon Therapeutics has 5 total employees.

  • What industry is Falcon Therapeutics in?

    Falcon Therapeutics’s primary industry is Drug Discovery.

  • Is Falcon Therapeutics a private or public company?

    Falcon Therapeutics is a Private company.

  • What is Falcon Therapeutics’s current revenue?

    The current revenue for Falcon Therapeutics is .

  • How much funding has Falcon Therapeutics raised over time?

    Falcon Therapeutics has raised $1.7M.

  • Who are Falcon Therapeutics’s investors?

    National Center For Advancing Translational Sciences has invested in Falcon Therapeutics.

  • Who are Falcon Therapeutics’s competitors?

    Adaptimmune Therapeutics is a competitor of Falcon Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process